“I am excited to lead Solera into its next stage of growth,” says Langowski.  “After already getting to know the company for several years, I’m thrilled to build on Solera’s success in diabetes prevention to tackle the most pressing and costly chronic conditions. Especially during COVID, it is critical to improve the consumer experience enabling them to stay healthy and meet them where they are, particularly in areas like weight management, smoking cessation and sleep, stress and resilience.”

“We are delighted to have someone of Mary’s caliber joining Solera at this critical stage in the company’s lifecycle,” says Matt Downs, Chairman of the Board at Solera Health and Managing Director of the Blue Venture Fund.  “She has an incredible track record of delivering results through strategic thinking combined with world-class execution.  We look forward to continuing to serve our payer customers by enabling them to better reach consumers and